Published in Blood Weekly, August 29th, 2002
"Tolerance-based stem cell transplantation using sublethal conditioning is being considered for the treatment of human disease, but safety and efficacy remain to be established," according to Daron Forman and colleagues at the University of Massachusetts in Worcester.
Animals treated with costimulatory blockade were capable of successful engraftment, but viral infection at the time of transplant had catastophic effects, Forman and coauthors found.
The researchers used a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.